But I am speaking about the science with regards to the tests used -
The test used is a behavioral test, whereas neuroscience has many better investigation techniques that have been standard for the last 25 years:
For example, the effects of Xanamem on long term potentiation (LTP) in the hippocampus would be the standard test for investigation of a new drug compound and its action(s) on cellular memory - this work seems to be missing.
Occupancy studies & binding to 11-beta-HSD-1 cortisol-activation enzyme have no direct link to memory.
I am hoping for some sophisticated science to put a link between Xanamem treatment and its impact on memory beyond the cited behavioural tests : )
- Forums
- ASX - By Stock
- ACW
- 11βHSD1 inhibitor use in human disease- a systematic review and narrative synthesis
11βHSD1 inhibitor use in human disease- a systematic review and narrative synthesis, page-62
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ACW (ASX) to my watchlist
(20min delay)
|
|||||
Last
9.0¢ |
Change
0.003(3.45%) |
Mkt cap ! $261.3M |
Open | High | Low | Value | Volume |
8.7¢ | 9.9¢ | 8.5¢ | $2.173M | 23.37M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 15000 | 9.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.2¢ | 48145 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 45067 | 0.091 |
3 | 197517 | 0.090 |
2 | 329840 | 0.089 |
3 | 721902 | 0.088 |
1 | 600000 | 0.087 |
Price($) | Vol. | No. |
---|---|---|
0.092 | 55468 | 3 |
0.093 | 508061 | 5 |
0.094 | 58722 | 2 |
0.095 | 65102 | 3 |
0.096 | 148518 | 1 |
Last trade - 15.57pm 18/07/2024 (20 minute delay) ? |
Featured News
ACW (ASX) Chart |